{"key":"op_790_CN","page":{"url":"https://pl.bookimed.com/clinics/country=china/procedure=target-therapy-for-lung-cancer/","procedure":{"id":790,"slug":"target-therapy-for-lung-cancer","name":"Terapia celowana przy raku płuc","name_forms":{"plural":{"status":"missing","reason":"not_collected"},"genitive":{"status":"missing","reason":"not_collected"}},"type":"therapy","grammar_number":{"status":"missing","reason":"not_collected"},"parent_id":"oncology","family_attribute":{"status":"missing","reason":"not_collected"}},"country":{"id":203,"iso":"CN","name":"Chiny"},"currency":"USD","data_date":"2026-11-05"},"pages":{"clinics_url":"https://pl.bookimed.com/clinics/country=china/procedure=target-therapy-for-lung-cancer/","cost_url":"https://pl.bookimed.com/clinics/country=china/procedure=target-therapy-for-lung-cancer/cost/","best_url":{"status":"missing","reason":"template not live"}},"price":{"from":1600,"to":13000,"avg":{"status":"missing","reason":"no_offers"},"us":{"from":90000,"to":150000},"uk":{"from":14000,"to":25000},"by_technique":{"status":"missing","reason":"not_collected"},"by_city":[{"city":"Szanghaj","from":1600},{"city":"Kanton","from":5500}],"per_unit":{"status":"missing","reason":"not_collected"},"factors":{"status":"missing","reason":"not_collected"},"tiers":{"status":"missing","reason":"no_offers"},"comparison":[{"country_iso":"UA","from":3500,"to":7000},{"country_iso":"FR","from":6500,"to":13000},{"country_iso":"GB","from":14000,"to":25000},{"country_iso":"US","from":90000,"to":150000},{"country_iso":"IL","from":9000,"to":16000},{"country_iso":"TR","from":5000,"to":5800},{"country_iso":"MX","from":6500,"to":12000},{"country_iso":"DE","from":3000,"to":27000},{"country_iso":"CA","from":9000,"to":20000},{"country_iso":"AE","from":9000,"to":14000},{"country_iso":"TH","from":9000,"to":13500},{"country_iso":"PL","from":4500,"to":8500},{"country_iso":"KR","from":2500,"to":15000},{"country_iso":"CZ","from":4500,"to":9000},{"country_iso":"AT","from":9000,"to":18000},{"country_iso":"ES","from":4500,"to":13000},{"country_iso":"IT","from":8200,"to":15900},{"country_iso":"AU","from":3800,"to":7500},{"country_iso":"IN","from":1000,"to":5500},{"country_iso":"MY","from":1800,"to":5400},{"country_iso":"VN","from":5000,"to":9500},{"country_iso":"BR","from":4500,"to":7000}],"base_country":"US","base_is_fallback":false},"savings":{"pct":98,"variant":">=15%"},"package":{"included":{"status":"missing","reason":"no_offers"},"excluded":{"status":"missing","reason":"no_offers"},"extra_charges":{"status":"missing","reason":"not_collected"}},"clinics":{"count":3,"items":[{"id":7869,"name":"Shanghai Tongji Hospital, International Department","city":"Shanghai","rating":{"status":"missing","reason":"not_collected"},"reviews_count":{"status":"missing","reason":"not_collected"},"accreditations":{"status":"missing","reason":"not_collected"},"rank":1,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":436,"name":"Fuda Cancer Hospital","city":"Guangzhou","rating":4.6,"reviews_count":19,"accreditations":{"status":"missing","reason":"not_collected"},"rank":2,"has_procedure":true,"why_ranked":"On-site FoundationOne CDx test maps 324 genes to match lung cancer patients to 1 of 17 approved targeted therapies. JCI-accredited, cooperating with MD Anderson Cancer Center.","bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":7193,"name":"Jinshazhou Hospital of Guangzhou University of Chinese Medicine","city":"Guangzhou","rating":{"status":"missing","reason":"not_collected"},"reviews_count":{"status":"missing","reason":"not_collected"},"accreditations":["Organisation of European Cancer Institutes Certificate"],"rank":3,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}}]},"doctors":{"count":7,"languages":{"status":"missing","reason":"not_collected"}},"cities":[{"id":2015,"slug":"shanghai","name":"Szanghaj","clinics_count":1,"price_from":1600,"profile":{"city_type":"Most populous city in China","access":["Pudong Airport (PVG), 30 km from the city center","Hongqiao Airport (SHA), 13 km from downtown"],"sources":["https://en.wikipedia.org/wiki/Shanghai","https://en.wikipedia.org/wiki/Shanghai_Pudong_International_Airport","https://en.wikipedia.org/wiki/Shanghai_Hongqiao_International_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":390,"slug":"guangzhou","name":"Kanton","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":5500,"profile":{"city_type":"Capital of Guangdong, southern China","access":["Guangzhou Baiyun Airport (CAN), 28 km north of downtown"],"sources":["https://en.wikipedia.org/wiki/Guangzhou","https://en.wikipedia.org/wiki/Guangzhou_Baiyun_International_Airport"],"checked_at":"2026-11-03","status":"ok"}}],"offers":{"active":{"status":"missing","reason":"no_offers"},"active_with_related":{"status":"missing","reason":"no_offers"},"hospital_nights_median":{"status":"missing","reason":"no_offers"},"days_in_country_median":{"status":"missing","reason":"no_offers"},"top_offers":{"status":"missing","reason":"no_offers"},"packages":{"status":"missing","reason":"no_offers"},"related_packages":{"status":"missing","reason":"no_offers"},"other_packages":{"status":"missing","reason":"no_offers"}},"medical":{"indications":["Advanced or metastatic NSCLC with EGFR exon 19 deletion","Advanced or metastatic NSCLC with EGFR L858R mutation","Adjuvant therapy after resection of EGFR-mutated NSCLC","Unresectable stage III EGFR-mutated NSCLC after chemoradiotherapy"],"contraindications":["Severe hypersensitivity to osimertinib or its components.","Current interstitial lung disease or pneumonitis.","Congenital long QT syndrome or uncorrectable electrolyte disturbances.","Clinically significant cardiomyopathy or reduced ventricular function.","Strong CYP3A4 inducers (rifampin, carbamazepine, phenytoin, St John's wort).","Pregnancy or planned conception (not recommended)."],"operation_hours":{"min":0.5,"max":3,"unit":"hours","qualifier":"Initial clinic visit for counseling and start; daily tablet takes minutes and therapy continues until progression."},"anesthesia":["none"],"sessions_or_stages":{"sessions":{"min":4,"max":8,"unit":"visits","qualifier":"Planned oncology reviews in the first 6 months from treatment start."},"stages":[{"code":"baseline_start","label":"Baseline assessment, counseling and start of daily oral therapy","after":{"min":0,"max":0,"unit":"days","qualifier":"Counted from treatment start."}},{"code":"early_tolerability_review","label":"Tolerability and laboratory review","after":{"min":14,"max":28,"unit":"days","qualifier":"After the first dose."}},{"code":"first_response_assessment","label":"First response imaging and clinic review","after":{"min":42,"max":84,"unit":"days","qualifier":"After the first dose; timing varies by clinic."}},{"code":"ongoing_scheduled_reviews","label":"Ongoing reviews with periodic imaging every 2 to 3 months","after":{"min":84,"max":180,"unit":"days","qualifier":"After the first dose; later intervals individualized."}}],"qualifier":"Daily oral osimertinib after biomarker confirmation, continued until progression or intolerance. Counts cover first 6 months only."},"hospital_nights":{"value":{"min":0,"max":0,"unit":"nights","qualifier":"Oral therapy taken at home; no hospital stay in an uncomplicated course. Infusion-based regimens are outside this profile."},"source":"parsed_details"},"treatment_conditions":["outpatient"],"rehabilitation_days":{"min":0,"max":7,"unit":"days","qualifier":"Oral therapy without procedure; time to settle into daily routine, affected by rash, diarrhea, fatigue and disease burden."},"fly_home_after_days":{"min":0,"max":14,"unit":"days","qualifier":"No procedure; travel is possible after baseline workup, once stable with enough medication. Tolerability review at about 2–4 weeks."},"back_to_work_days":{"min":0,"max":7,"unit":"days","qualifier":"No procedure or stay; many patients with good performance status work within a week, adjusted for side effects."},"exercise_resume_weeks":{"min":0,"max":2,"unit":"weeks","qualifier":"Light activity from day 1; strenuous exercise gradually over 1 to 2 weeks if tolerability and breathing allow."},"final_result_months":{"min":1,"max":3,"unit":"months","qualifier":"Time to first radiologic response assessment, about 6 to 12 weeks. Not a cure endpoint; therapy continues."},"result_longevity":"Disease control typically lasts months to a few years until resistance develops; median first-line progression-free survival was roughly 1.5 years. Benefit lasts only during therapy; not a cure.","main_risks":["Diarrhea, dry skin, rash, paronychia, mouth sores; usually manageable.","Interstitial lung disease: rare but serious; stop drug, urgent evaluation.","QT prolongation; rarely reduced heart function.","Low blood counts and liver enzyme changes found on monitoring.","Eye symptoms and rare severe skin reactions.","Drug interactions, especially with CYP3A4 inducers."],"complication_rate_pct":{"min":1,"max":5,"unit":"percent","qualifier":"Approximate rate of interstitial lung disease or pneumonitis on osimertinib; milder effects like rash and diarrhea are far more common."},"revision_rate_pct":{"status":"missing","reason":"not_collected"},"success":{"metric":"Objective response rate (tumor shrinkage on imaging)","value":80,"horizon":"First response imaging, about 6 to 12 weeks after first dose","source":{"status":"missing","reason":"not_collected"},"evidence_status":"limited"},"scars":"None; no incisions.","pain":"Taking the oral tablet is painless. Treatment-related discomfort, such as mouth sores, nail-fold tenderness, rash or headache, can occur and is managed symptomatically.","preparation":["Confirm NSCLC and EGFR mutation by tissue or liquid biopsy","Baseline staging, usually CT with brain imaging, per the oncologist.","Baseline blood counts, liver and kidney tests, electrolytes","ECG and cardiac assessment as indicated","Review all medicines and supplements for CYP3A4 and QT interactions.","Counseling on side effects, dosing, skin and nail care","Contraception advice and when to contact the oncology team"],"recovery_timeline":[{"phase":"Treatment start (day 0)","description":"Baseline assessment and counseling, then daily oral osimertinib starts at home. No hospital stay; light activity continues from day 1.","restrictions":["Take the tablet daily as directed","Avoid interacting drugs and supplements unless cleared","Use contraception as advised"]},{"phase":"Days 1 to 28","description":"Mild diarrhea, dry skin, rash, nail changes, mouth sores and fatigue may appear; supportive care helps. Exercise resumes gradually.","restrictions":["Daily skin, nail and mouth care","Maintain hydration","Increase exercise gradually, guided by oncology team"]},{"phase":"Weeks 6 to 12","description":"First response imaging and clinic review; initial response is judged and monitoring continues.","restrictions":["Continue treatment unless the oncology team advises otherwise"]},{"phase":"Ongoing therapy (months 3 to 6 and beyond)","description":"Daily therapy with periodic reviews and imaging until progression or intolerance; repeat testing if disease progresses.","restrictions":["Continue regular monitoring as scheduled","Do not stop or change dose without oncology advice"]},{"phase":"At any time","description":"Seek urgent care for new cough, breathlessness, fever, chest pain, palpitations, severe diarrhea, severe rash, eye pain, or infection or bleeding signs.","restrictions":["Do not wait for the next review","Team may pause the drug during assessment"]}],"follow_up_visits":[{"purpose":"assessment","requirement":"routine","after":{"min":14,"max":28,"unit":"days","qualifier":"After the first dose; tolerability and laboratory review."}},{"purpose":"result_review","requirement":"routine","after":{"min":42,"max":84,"unit":"days","qualifier":"After the first dose; first response imaging and clinic review."}},{"purpose":"assessment","requirement":"routine","after":{"min":84,"max":180,"unit":"days","qualifier":"After the first dose; periodic imaging every 2 to 3 months, later intervals individualized."}}],"sources":{"status":"missing","reason":"not_collected"},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check that the doctor explains the risks of any biopsy needed for the tumor before it is done","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Your doctor will explain the risks of having a biopsy for your type of tumor.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C2","text":"Check whether the doctor explains that cancer cells can become resistant to targeted therapy","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Cancer cells can become resistant to targeted therapy.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C3","text":"Check the plan for regular visits, blood tests and scans, which show whether the treatment is working","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"These regular visits and tests will help the doctor know whether the treatment is working.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C4","text":"Check that the side effects of the specific targeted drug you would receive are explained before treatment starts","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"The side effects that you may have depends on the type of targeted therapy you receive and how your body reacts to it.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C5","text":"Check that your tumor has been tested for drug targets, which is needed most of the time","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"But most of the time, your tumor will need to be tested to see if it contains targets for which there is a drug.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Promise that the doctor can know for certain how you will feel during treatment","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Doctors and nurses cannot know for certain how you will feel during treatment.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"F2","text":"Ad or quote calling targeted therapy free of serious side effects","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"But they have learned that targeted therapy can also cause serious side effects.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"F3","text":"Targeted therapy offered without any mention of testing the tumor for drug targets","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"But most of the time, your tumor will need to be tested to see if it contains targets for which there is a drug.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"warning_signs":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-14","next_check_at":"2027-02-12"},"take_home":{"status":"ok","items":[{"id":"T1","text":"Home doctor needs the clinic's follow-up recommendations in a written discharge summary","document":"discharge summary","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"When you have treatment abroad, you must ask the treatment provider for their follow-up recommendations documented within a written discharge summary in English.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T2","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T3","text":"Home doctor needs the dates for required blood tests and follow-up appointments","document":"written aftercare plan","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1}},"parsed_details":{"procedure_type":"therapy","fields":{"anesthesia":["none"],"back_to_work_days":{"min":0,"max":7,"unit":"days","qualifier":"No procedure or stay; many patients with good performance status work within a week, adjusted for side effects."},"complication_rate_pct":{"min":1,"max":5,"unit":"percent","qualifier":"Approximate rate of interstitial lung disease or pneumonitis on osimertinib; milder effects like rash and diarrhea are far more common."},"contraindications":["Severe hypersensitivity to osimertinib or its components.","Current interstitial lung disease or pneumonitis.","Congenital long QT syndrome or uncorrectable electrolyte disturbances.","Clinically significant cardiomyopathy or reduced ventricular function.","Strong CYP3A4 inducers (rifampin, carbamazepine, phenytoin, St John's wort).","Pregnancy or planned conception (not recommended)."],"days_in_clinic":{"min":0,"max":0,"unit":"nights","qualifier":"Oral therapy taken at home; no hospital stay in an uncomplicated course. Infusion-based regimens are outside this profile."},"diagnostic_duration_minutes":null,"diagnostic_preparation":null,"diagnostic_referral_needed":null,"diagnostic_result_time_hours":null,"exercise_resume_weeks":{"min":0,"max":2,"unit":"weeks","qualifier":"Light activity from day 1; strenuous exercise gradually over 1 to 2 weeks if tolerability and breathing allow."},"final_result_months":{"min":1,"max":3,"unit":"months","qualifier":"Time to first radiologic response assessment, about 6 to 12 weeks. Not a cure endpoint; therapy continues."},"fly_home_after_days":{"min":0,"max":14,"unit":"days","qualifier":"No procedure; travel is possible after baseline workup, once stable with enough medication. Tolerability review at about 2–4 weeks."},"follow_up_visits":[{"purpose":"assessment","requirement":"routine","after":{"min":14,"max":28,"unit":"days","qualifier":"After the first dose; tolerability and laboratory review."}},{"purpose":"result_review","requirement":"routine","after":{"min":42,"max":84,"unit":"days","qualifier":"After the first dose; first response imaging and clinic review."}},{"purpose":"assessment","requirement":"routine","after":{"min":84,"max":180,"unit":"days","qualifier":"After the first dose; periodic imaging every 2 to 3 months, later intervals individualized."}}],"indications":["Advanced or metastatic NSCLC with EGFR exon 19 deletion","Advanced or metastatic NSCLC with EGFR L858R mutation","Adjuvant therapy after resection of EGFR-mutated NSCLC","Unresectable stage III EGFR-mutated NSCLC after chemoradiotherapy"],"main_risks":["Diarrhea, dry skin, rash, paronychia, mouth sores; usually manageable.","Interstitial lung disease: rare but serious; stop drug, urgent evaluation.","QT prolongation; rarely reduced heart function.","Low blood counts and liver enzyme changes found on monitoring.","Eye symptoms and rare severe skin reactions.","Drug interactions, especially with CYP3A4 inducers."],"pain":"Taking the oral tablet is painless. Treatment-related discomfort, such as mouth sores, nail-fold tenderness, rash or headache, can occur and is managed symptomatically.","preparation":["Confirm NSCLC and EGFR mutation by tissue or liquid biopsy","Baseline staging, usually CT with brain imaging, per the oncologist.","Baseline blood counts, liver and kidney tests, electrolytes","ECG and cardiac assessment as indicated","Review all medicines and supplements for CYP3A4 and QT interactions.","Counseling on side effects, dosing, skin and nail care","Contraception advice and when to contact the oncology team"],"recovery_timeline":[{"phase":"Treatment start (day 0)","description":"Baseline assessment and counseling, then daily oral osimertinib starts at home. No hospital stay; light activity continues from day 1.","restrictions":["Take the tablet daily as directed","Avoid interacting drugs and supplements unless cleared","Use contraception as advised"]},{"phase":"Days 1 to 28","description":"Mild diarrhea, dry skin, rash, nail changes, mouth sores and fatigue may appear; supportive care helps. Exercise resumes gradually.","restrictions":["Daily skin, nail and mouth care","Maintain hydration","Increase exercise gradually, guided by oncology team"]},{"phase":"Weeks 6 to 12","description":"First response imaging and clinic review; initial response is judged and monitoring continues.","restrictions":["Continue treatment unless the oncology team advises otherwise"]},{"phase":"Ongoing therapy (months 3 to 6 and beyond)","description":"Daily therapy with periodic reviews and imaging until progression or intolerance; repeat testing if disease progresses.","restrictions":["Continue regular monitoring as scheduled","Do not stop or change dose without oncology advice"]},{"phase":"At any time","description":"Seek urgent care for new cough, breathlessness, fever, chest pain, palpitations, severe diarrhea, severe rash, eye pain, or infection or bleeding signs.","restrictions":["Do not wait for the next review","Team may pause the drug during assessment"]}],"rehabilitation_days":{"min":0,"max":7,"unit":"days","qualifier":"Oral therapy without procedure; time to settle into daily routine, affected by rash, diarrhea, fatigue and disease burden."},"result_longevity":"Disease control typically lasts months to a few years until resistance develops; median first-line progression-free survival was roughly 1.5 years. Benefit lasts only during therapy; not a cure.","revision_rate_pct":null,"scars":"None; no incisions.","sessions_or_stages":{"sessions":{"min":4,"max":8,"unit":"visits","qualifier":"Planned oncology reviews in the first 6 months from treatment start."},"stages":[{"code":"baseline_start","label":"Baseline assessment, counseling and start of daily oral therapy","after":{"min":0,"max":0,"unit":"days","qualifier":"Counted from treatment start."}},{"code":"early_tolerability_review","label":"Tolerability and laboratory review","after":{"min":14,"max":28,"unit":"days","qualifier":"After the first dose."}},{"code":"first_response_assessment","label":"First response imaging and clinic review","after":{"min":42,"max":84,"unit":"days","qualifier":"After the first dose; timing varies by clinic."}},{"code":"ongoing_scheduled_reviews","label":"Ongoing reviews with periodic imaging every 2 to 3 months","after":{"min":84,"max":180,"unit":"days","qualifier":"After the first dose; later intervals individualized."}}],"qualifier":"Daily oral osimertinib after biomarker confirmation, continued until progression or intolerance. Counts cover first 6 months only."},"success":{"metric":"Objective response rate (tumor shrinkage on imaging)","value":80,"unit":"percent","horizon":"First response imaging, about 6 to 12 weeks after first dose","population":"Adults with advanced EGFR exon 19 or L858R NSCLC on first-line osimertinib","evidence_status":"limited"},"techniques":[{"name":"Oral EGFR tyrosine kinase inhibitor (osimertinib)","suits_whom":"Adults with EGFR-mutated advanced NSCLC.","recovery":"Taken at home daily; no procedural recovery, with side-effect management and monitoring as directed."},{"name":"Other oral targeted inhibitors (ALK, ROS1, RET, MET, BRAF/MEK, KRAS G12C, HER2)","suits_whom":"Patients with the matching actionable alteration; the choice follows biomarker results and approvals.","recovery":"Taken at home as continuous therapy; monitoring and side effects are agent-specific."},{"name":"Antibody-based targeted regimens, such as EGFR-MET bispecific antibody or antibody-drug conjugates","suits_whom":"Selected patients with specific alterations or after progression on oral inhibitors; availability varies.","recovery":"Given by intravenous infusion in a treatment unit; schedules and observation are product-specific."}],"treatment_conditions":["outpatient"],"treatment_duration_hours":{"min":0.5,"max":3,"unit":"hours","qualifier":"Initial clinic visit for counseling and start; daily tablet takes minutes and therapy continues until progression."},"initial_assessment_documents":["Lung biopsy pathology report","EGFR and other biomarker test report (NGS)","Chest CT or PET-CT report and images","Brain MRI report","Recent blood tests with liver and kidney function","Previous cancer treatment summary (if available)"],"travel_trips":{"min":1,"max":3,"one_trip_possible":true,"qualifier":"Daily oral therapy; one 1-2 week trip covers workup and start; imaging and reviews may need return trips."},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check that the doctor explains the risks of any biopsy needed for the tumor before it is done","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Your doctor will explain the risks of having a biopsy for your type of tumor.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C2","text":"Check whether the doctor explains that cancer cells can become resistant to targeted therapy","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Cancer cells can become resistant to targeted therapy.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C3","text":"Check the plan for regular visits, blood tests and scans, which show whether the treatment is working","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"These regular visits and tests will help the doctor know whether the treatment is working.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C4","text":"Check that the side effects of the specific targeted drug you would receive are explained before treatment starts","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"The side effects that you may have depends on the type of targeted therapy you receive and how your body reacts to it.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C5","text":"Check that your tumor has been tested for drug targets, which is needed most of the time","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"But most of the time, your tumor will need to be tested to see if it contains targets for which there is a drug.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Promise that the doctor can know for certain how you will feel during treatment","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Doctors and nurses cannot know for certain how you will feel during treatment.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"F2","text":"Ad or quote calling targeted therapy free of serious side effects","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"But they have learned that targeted therapy can also cause serious side effects.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"F3","text":"Targeted therapy offered without any mention of testing the tumor for drug targets","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"But most of the time, your tumor will need to be tested to see if it contains targets for which there is a drug.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"warning_signs":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-14","next_check_at":"2027-02-12"},"take_home":{"status":"ok","items":[{"id":"T1","text":"Home doctor needs the clinic's follow-up recommendations in a written discharge summary","document":"discharge summary","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"When you have treatment abroad, you must ask the treatment provider for their follow-up recommendations documented within a written discharge summary in English.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T2","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T3","text":"Home doctor needs the dates for required blood tests and follow-up appointments","document":"written aftercare plan","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"alternatives":{"status":"ok","items":[{"id":"A1","text":"Your lung cancer can be removed with surgery","name":"Lung cancer surgery","source":{"url":"https://www.nhs.uk/conditions/lung-cancer/treatment/","host":"nhs.uk","quote":"You may have surgery to remove cancer from your lung.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200},"operation_id":374}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"technique_details":{"status":"ok","items":[{"id":"oral-egfr-tyrosine","name":"Oral EGFR tyrosine kinase inhibitor (osimertinib)","how_it_works":{"text":"Targeted medicines kill cancer cells or stop them growing","source":{"url":"https://www.nhs.uk/conditions/lung-cancer/treatment/","host":"nhs.uk","quote":"Targeted medicines kill cancer cells or stop them growing as quickly.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"other-oral-targeted","name":"Other oral targeted inhibitors (ALK, ROS1, RET, MET, BRAF/MEK, KRAS G12C, HER2)","how_it_works":{"text":"Targeted medicines kill cancer cells or stop them growing","source":{"url":"https://www.nhs.uk/conditions/lung-cancer/treatment/","host":"nhs.uk","quote":"Targeted medicines kill cancer cells or stop them growing as quickly.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"antibody-based-targeted","name":"Antibody-based targeted regimens, such as EGFR-MET bispecific antibody or antibody-drug conjugates","how_it_works":{"text":"Targeted medicines kill cancer cells or stop them growing","source":{"url":"https://www.nhs.uk/conditions/lung-cancer/treatment/","host":"nhs.uk","quote":"Targeted medicines kill cancer cells or stop them growing as quickly.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1}}},"techniques":[{"id":"oral-egfr-tyrosine","name":"Oral EGFR tyrosine kinase inhibitor (osimertinib)","how_it_works":{"id":"H1","text":"Targeted medicines kill cancer cells or stop them growing","source":{"url":"https://www.nhs.uk/conditions/lung-cancer/treatment/","host":"nhs.uk","quote":"Targeted medicines kill cancer cells or stop them growing as quickly.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Adults with EGFR-mutated advanced NSCLC.","price_from":{"status":"missing","reason":"not_collected"},"recovery":"Taken at home daily; no procedural recovery, with side-effect management and monitoring as directed."},{"id":"other-oral-targeted","name":"Other oral targeted inhibitors (ALK, ROS1, RET, MET, BRAF/MEK, KRAS G12C, HER2)","how_it_works":{"id":"H1","text":"Targeted medicines kill cancer cells or stop them growing","source":{"url":"https://www.nhs.uk/conditions/lung-cancer/treatment/","host":"nhs.uk","quote":"Targeted medicines kill cancer cells or stop them growing as quickly.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Patients with the matching actionable alteration; the choice follows biomarker results and approvals.","price_from":{"status":"missing","reason":"not_collected"},"recovery":"Taken at home as continuous therapy; monitoring and side effects are agent-specific."},{"id":"antibody-based-targeted","name":"Antibody-based targeted regimens, such as EGFR-MET bispecific antibody or antibody-drug conjugates","how_it_works":{"id":"H1","text":"Targeted medicines kill cancer cells or stop them growing","source":{"url":"https://www.nhs.uk/conditions/lung-cancer/treatment/","host":"nhs.uk","quote":"Targeted medicines kill cancer cells or stop them growing as quickly.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Selected patients with specific alterations or after progression on oral inhibitors; availability varies.","price_from":{"status":"missing","reason":"not_collected"},"recovery":"Given by intravenous infusion in a treatment unit; schedules and observation are product-specific."}],"alternatives":{"status":"ok","items":[{"id":"A1","text":"Your lung cancer can be removed with surgery","name":"Lung cancer surgery","source":{"url":"https://www.nhs.uk/conditions/lung-cancer/treatment/","host":"nhs.uk","quote":"You may have surgery to remove cancer from your lung.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200},"operation_id":374}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"diagnostic":{"status":"not_applicable"},"country":{"why":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-11","next_check_at":"2027-02-09"},"travel":{"status":"ok","items":[{"id":"V1","item":"visa","audience":"uk","volatile":true,"text":"British citizens can enter China without a visa for up to 30 days for business, tourism, family or friend visits, or transit, for a limited period","source":{"url":"https://www.gov.uk/foreign-travel-advice/china/entry-requirements","host":"gov.uk","quote":"Until 31 December 2026, you can enter China visa free for stays of up to 30 days for business, tourism, family or friend visits or transit.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V2","item":"visa","audience":"us","volatile":true,"text":"US citizens must obtain a visa before arriving in China","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/China.html","host":"travel.state.gov","quote":"You must obtain a visa prior to arriving in the People’s Republic of China (PRC).","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V3","item":"passport_validity","audience":"uk","volatile":true,"text":"A UK passport must expire at least 6 months after arrival in China and have 2 blank pages for visas and stamping","source":{"url":"https://www.gov.uk/foreign-travel-advice/china/entry-requirements","host":"gov.uk","quote":"To enter China, your passport must have an ‘expiry date’ at least 6 months after the date you arrive and 2 blank pages for visas and stamping.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V4","item":"passport_validity","audience":"us","volatile":true,"text":"A US passport must have at least six months of validity remaining to enter China","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/China.html","host":"travel.state.gov","quote":"Your passport must have at least six months' validity remaining.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V5","item":"medicines","audience":"us","volatile":false,"text":"Carry prescription medication for China in its original packaging, along with the prescription","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/China.html","host":"travel.state.gov","quote":"Carry prescription medication in original packaging, along with the prescription.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V6","item":"hospital_payment","audience":"all","volatile":false,"text":"Hospitals in China often require payment in cash or by mobile payment app before treatment, including emergency cases","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/China.html","host":"travel.state.gov","quote":"Payment in cash or via mobile payment app for services is often required prior to treatment, including emergency cases.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V7","item":"emergency_number","audience":"all","volatile":false,"text":"Call 120 and ask for an ambulance in China","source":{"url":"https://www.gov.uk/foreign-travel-advice/china/health","host":"gov.uk","quote":"Call 120 and ask for an ambulance.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2026-12-11","version":1},"other_countries_with_page":["egypt","germany","india","republic-of-korea","spain","switzerland","thailand","turkey","ukraine"]},"often_combined_with":{"status":"missing","reason":"not_collected"},"reviews":{"avg_rating":4.6,"count":19,"scope":"clinic","rating_scale":5,"pros":{"status":"missing","reason":"not_collected"},"cons":{"status":"missing","reason":"not_collected"}},"current":{"seo_text":"<p>Target therapy for lung cancer in China typically costs from _op_790_price_from_ to _op_790_price_to_. The final price depends on the drug generation, hospital tier, and whether medications are domestic or imported. In the US, similar procedures cost around _price_compare_US_average_ on average. China offers savings of around _price_percent_discount_%. Treatment usually includes diagnostic genomic profiling, medication, and specialized oncology consultations.</p>\n\n<ul>\n<li><strong>Domestic medications:</strong> Locally manufactured targeted therapies often cost 50% less than multinational brands.</li>\n<li><strong>Hospital tier:</strong> Private international centers in Guangzhou and Chengdu charge 50-100% more than public hospitals.</li>\n<li><strong>Drug generation:</strong> Newer third-generation targeted agents command higher premiums than first-generation generic competitors.</li>\n<li><strong>Diagnostic workup:</strong> Comprehensive genomic profiling via NGS panels typically adds significant costs to the baseline.</li>\n</ul>\n\n<p><strong>Bookimed Expert Insight:</strong> Choosing JCI-accredited centers like Fuda Cancer Hospital provides Western-standard care at significantly lower prices. Fuda Cancer Hospital maintains a partnership with MD Anderson Cancer Center while offering costs 2–3 times lower. For complex cases, Uni-asia Cancer Hospital features experts like Xiao Yueyong, who leads national ablation standards. Patients often benefit from free airport transfers and multilingual interpreters included in these specialized oncology packages.</p>","faq":{"status":"missing","reason":"not_collected"},"h2":[{"text":"Jaka jest cena terapii celowanej przy raku płuc w Chinach? Proszę dowiedzieć się teraz","kind":"content"},{"text":"Państwa korzyści i gwarancje z Bookimed","kind":"content"},{"text":"Wasz osobisty lekarz-koordynator Bookimed","kind":"content"},{"text":"Dowiedzieć się o najlepszych klinikach w terapii celowanej przy raku płuc w Chinach: 3 sprawdzone kliniki i ceny","kind":"content"},{"text":"Przegląd procedury Terapia celowana przy raku płuc w Chinach","kind":"content"},{"text":"Uzyskać ocenę medyczną dla terapii celowanej przy raku płuc w Chinach: znaleźć swojego specjalistę wśród 7 doświadczonych lekarzy","kind":"content"},{"text":"Wideo historie pacjentów Bookimed","kind":"content"},{"text":"Opinie o Bookimed: poznać prawdziwe doświadczenia pacjentów","kind":"content"},{"text":"Udostępnić tę treść","kind":"content"},{"text":"Uzyskać bezpłatną konsultację","kind":"content"}]},"placeholders":{"price_from":"{{price_from}}","clinics_count":"{{clinics_count}}","cities_count":"{{cities_count}}","savings_pct":"{{savings_pct}}","data_date":"{{data_date}}"},"legal":{"restricted_markets":{"status":"missing","reason":"not_collected"}},"conflicts":[]}